1 October, 2018

SUPERIOR

2024-02-07T15:50:04+03:00By |Categories: Completed, Interventional, Sepsis and severe infections, Studies|Tags: |

Completed study Official Study Title a SUPar guided doublE-blind Randomized clinical trial of Initiation Of antibiotics foR presumed infection at the emergency department Brief Description SUPERIOR is a randomized clinical trial aiming to evaluate suPAR - guided medical intervention, consisting of early antibiotic administration at the emergency room for presumed infection and sepsis and

1 October, 2018

How well does qSOFA correspond to underlying systemic inflammatory response?

2023-02-16T14:38:02+03:00By |Categories: Biomarkers, Publications|Tags: , |

Karolina Akinosoglou, Spyridoula Theodoraki, Theologia Gkavogianni, Aikaterini Pistiki, Evangelos J. Giamarellos-Bourboulis, Charalambos A Gogos Cytokine 2018 Oct;110:288-290 DOI: 10.1016/j.cyto.2018.01.019View article 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis. Keywords: Anti-inflammatory mediators; Pro-inflammatory mediators; SIRS; Sepsis; qSOFA

1 June, 2018

Reduced circulating B cells and plasma IgM levels are associated with decreased survival in sepsis – A meta-analysis

2023-02-16T14:38:40+03:00By |Categories: Biomarkers, Publications|Tags: , |

Christian Krautz, Sarah L Maier, Maximilian Brunner, Melanie Langheinrich, Evangelos J. Giamarellos-Bourboulis, Charalambos Gogos, Apostolos Armaganidis, Frank Kunath, Robert Grützmann, Georg F Weber Journal of Critical Care 2018 Jun;45:71-75 DOI: 10.1016/j.jcrc.2018.01.013 View article 🡇 Keywords: Circulating B cells; Plasma IgM; Sepsis; Sepsis outcome

29 May, 2018

Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection

2024-03-28T17:18:57+03:00By |Categories: Pathogenesis, Publications|Tags: |

Dimitrios Sinapidis, Vassileios Kosmas, Vasileios Vittoros, Ioannis M. Koutelidakis, Aikaterini Pantazi, Aggelos Stefos, Konstantinos E. Katsaros, Karolina Akinosoglou, Magdalini Bristianou, Konstantinos Toutouzas, Michael Chrisofos and Evangelos J. Giamarellos-Bourboulis BMC Infectious Diseases, May 2018 DOI 10.1186/s12879-018-3156-zDownload pdf 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis.

3 March, 2018

Increases in inflammatory and CD14dim/CD16pos/CD45pos patrolling monocytes in sepsis: correlation with final outcome

2023-02-16T14:39:51+03:00By |Categories: Other Grants, Publications|Tags: |

Gabriela Gainaru, Antonios Papadopoulos, Iraklis Tsangaris, Malvina Lada, Evangelos J. Giamarellos-Bourboulis, Aikaterini Pistiki Critical Care 2018 Mar 3;22(1):56 DOI: 10.1186/s13054-018-1977-1View article 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis. Keywords: Gram-negative; Inflammatory monocytes; Patrolling monocytes; Sepsis; Survival

1 February, 2018

Haplotypes composed of minor frequency single nucleotide polymorphisms of the TNF gene protect from progression into sepsis: A study using the new sepsis classification

2024-03-28T17:04:25+03:00By |Categories: Genetics, Publications|Tags: , |

Theodoros Retsas, Klaus Huse, Lazaros-Dimitrios Lazaridis, Niki Karampela, Michael Bauer, Matthias Platzer, Virginia Kolonia, Eirini Papageorgiou, Evangelos J. Giamarellos-Bourboulis, George Dimopoulos International Journal of Infectious Diseases 2018 Feb;67:102-106 DOI: 10.1016/j.ijid.2017.12.008Download pdf 🡇 FundingThe study was funded in part by the Hellenic Institute for the Study of Sepsis and by the Federal Ministry of

1 December, 2017

PROVIDE

2024-10-18T11:36:45+03:00By |Categories: Completed, Interventional, Sepsis and severe infections, Studies|Tags: , |

Completed study Official Study Title A Personalized Randomized Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis (PROVIDE) Brief Description PROVIDE is a randomized clinical trial aiming to the personalized therapy of patients at septic shock. Using biomarkers, enrolled patients are randomized through a double-dummy approach to immunotherapy or placebo

1 December, 2017

INCLASS

2023-01-09T12:15:00+03:00By |Categories: Completed, Interventional, Sepsis and severe infections, Studies|Tags: , |

Completed study Official Study Title A double-blind, randomized, placebo-controlled clinical study of the efficacy of INtravenous CLArithromycin as adjunctive treatment in patients with Sepsis and respiratory and multiple organ dysfunction Syndrome Brief Description INCLASS is a randomized clinical trial aiming to compare the efficacy of intravenous clarithromycin over placebo in patients with sepsis and

1 December, 2017

Platelet reactivity in sepsis syndrome: results from the PRESS study

2023-02-16T15:08:41+03:00By |Categories: Pathogenesis, Publications|Tags: |

Karolina Akinosoglou, Spyridoula Theodoraki, Ioanna Xanthopoulou, Angelos Perperis, Theologia Gkavogianni, Aikaterini Pistiki, Evangelos J Giamarellos-Bourboulis, Charalambos A Gogos European Journal of Clinical Microbiology & Infectious Diseases 2017 Dec;36(12):2503-2512 DOI: 10.1007/s10096-017-3093-6View the article 🡇 Funding This work was funded by the Hellenic Institute for the Study of Sepsis. Keywords: Organ dysfunction; P2Y12 platelet

1 November, 2017

Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae

2023-02-16T15:10:33+03:00By |Categories: Pathogenesis, Publications|Tags: |

S Christodoulou, E Kyriazopoulou, M Chrysanthakopoulou, G Karlis, I Karampela, K Gkizeli, N Veliki, A Safarika, E J Giamarellos-Bourboulis, G Adamis; Hellenic Sepsis Study Group European Journal of Clinical Microbiology & Infectious Diseases 2017 Nov;36(11):2171-2177 DOI: 10.1007/s10096-017-3041-5View article 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis.

Go to Top